Serial Number | 88749349 |
Word Mark | CENMIRA |
Filing Date | Tuesday, January 7, 2020 |
Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
Status Date | Monday, August 14, 2023 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | Tuesday, May 19, 2020 |
Goods and Services | Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease; Pharmaceutical preparations for the prevention and treatment of depression; Pharmaceutical preparations for the prevention and treatment of psychological disorders; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of cardiovascular and blood pressure disorders; Pharmaceutical preparations for the prevention and treatment of irritable bowel syndrome; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of osteoporosis; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of sexual dysfunction; Pharmaceutical preparations for the prevention and treatment of symptoms associated with uterine fibroids; Pharmaceutical preparations for the prevention and treatment of urinary incontinence and overactive bladder; Pharmaceutical preparations for the prevention and treatment of AIDS-related disorders; Pharmaceutical preparations that support, encourage and promote bone strength; Pharmaceutical preparations that support, encourage and promote bone health; Pharmaceutical preparations used in the treatment of bone disorders and bone diseases; Pharmaceutical preparations, namely, injectable contraceptives; Pharmaceutical preparations, namely, contraceptive preparations; Pharmaceutical preparations, namely, fertility enhancement preparations; Pharmaceutical preparations, namely, hormone replacement therapy preparations; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical agents affecting the central nervous system; Pharmaceutical agents affecting circulatory systems; Pharmaceutical agents affecting sensory organs; Pharmaceutical agents affecting urogenital organs; Pharmaceutical agents affecting peripheral nervous system; Pharmaceutical preparations for the treatment of neurological disorders |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Friday, January 10, 2020 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | Teva Pharmaceutical Industries Limited |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 99 - Other |
Address | Petach Tikva 49131 IL |
Party Name | Teva Pharmaceutical Industries Limited |
Party Type | 10 - Original Applicant |
Legal Entity Type | 99 - Other |
Address | Petach Tikva 49131 IL |
Event Date | Event Description |
Monday, August 14, 2023 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
Monday, August 14, 2023 | ABANDONMENT - NO USE STATEMENT FILED |
Thursday, June 29, 2023 | ASSIGNED TO EXAMINER |
Thursday, February 2, 2023 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
Thursday, February 2, 2023 | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS |
Thursday, February 2, 2023 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
Thursday, February 2, 2023 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
Thursday, January 26, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Wednesday, January 25, 2023 | SOU EXTENSION 5 GRANTED |
Monday, January 9, 2023 | SOU EXTENSION 5 FILED |
Wednesday, January 25, 2023 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
Monday, January 9, 2023 | SOU TEAS EXTENSION RECEIVED |
Saturday, July 16, 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Thursday, July 14, 2022 | SOU EXTENSION 4 GRANTED |
Thursday, July 14, 2022 | SOU EXTENSION 4 FILED |
Thursday, July 14, 2022 | SOU TEAS EXTENSION RECEIVED |
Thursday, July 7, 2022 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
Thursday, July 7, 2022 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
Thursday, July 7, 2022 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
Saturday, January 8, 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Thursday, January 6, 2022 | SOU EXTENSION 3 GRANTED |
Thursday, January 6, 2022 | SOU EXTENSION 3 FILED |
Thursday, January 6, 2022 | SOU TEAS EXTENSION RECEIVED |
Thursday, July 15, 2021 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Tuesday, July 13, 2021 | SOU EXTENSION 2 GRANTED |
Tuesday, July 13, 2021 | SOU EXTENSION 2 FILED |
Tuesday, July 13, 2021 | SOU TEAS EXTENSION RECEIVED |
Friday, December 18, 2020 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Wednesday, December 16, 2020 | SOU EXTENSION 1 GRANTED |
Wednesday, December 16, 2020 | SOU EXTENSION 1 FILED |
Wednesday, December 16, 2020 | SOU TEAS EXTENSION RECEIVED |
Tuesday, July 14, 2020 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
Tuesday, May 19, 2020 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Tuesday, May 19, 2020 | PUBLISHED FOR OPPOSITION |
Wednesday, April 29, 2020 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Friday, April 10, 2020 | ASSIGNED TO LIE |
Friday, April 3, 2020 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Wednesday, April 1, 2020 | EXAMINER'S AMENDMENT ENTERED |
Wednesday, April 1, 2020 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
Wednesday, April 1, 2020 | EXAMINERS AMENDMENT E-MAILED |
Wednesday, April 1, 2020 | EXAMINERS AMENDMENT -WRITTEN |
Friday, March 27, 2020 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Friday, March 27, 2020 | NON-FINAL ACTION E-MAILED |
Friday, March 27, 2020 | NON-FINAL ACTION WRITTEN |
Thursday, March 26, 2020 | ASSIGNED TO EXAMINER |
Friday, January 10, 2020 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Friday, January 10, 2020 | NEW APPLICATION ENTERED |